
The Drug Controller General of India (DCGI) said on Monday that a committee will be set up to examine whether Unwanted 72 and i-pill, two morning-after contraceptive pills, now sold over the counter, should be reclassified as “prescription drugs.” Unwanted 72 is made by Mankind Pharma, Cipla manufactures the i-pill.
This comes after the DCGI sent a letter to the two manufacturers last month pulling them up for running TV ads it claimed were “misrepresenting abortion” and pushing the pills as a way to be “tension-free” after sex.
As per norms, if these two pills are categorised as prescription drugs, they cannot be advertised.
Speaking to The Indian Express, Surinder Singh, Drug Controller General of India, said today that the Drug Technical Advisory Board will meet on November 9 on the issue.
“We will go by the DTAB’s decision. A committee may be set up to research and speak to the companies. This will help us understand whether we should revise the ads or whether these OTC drugs be made prescription drugs. It may take two to three months to look at the subject in totality,” Singh said.
Singh claimed the ads do not emphasize that the pills are only for “emergency” use, show abortion in a bad light and do not mention the side effects of the pills. “Even a mutual fund ad, in a short span of time on air, will ask you to read the fine print. But these ads do not focus on the side effects,” Singh said.
... contd.